Session Chair Profile
Ph.D., Vice President, Medical Oncology, BMS
Biography
Maria Karasarides leads medical strategy and innovation for the oncology early development portfolio. With an applied focus on innovative technologies and biomarkers, she oversees the integration of medical research designed to address realworld problems that impede clinical outcomes and meaningfully bridge research into clinical practice and patient care. Her experience spans the academic and pharmaceutical sectors with a focus on clinical and translational development. She held leadership positions at Regeneron Pharmaceuticals, AstraZeneca and Bristol Myers Squibb where she advanced the development of investigational immune modulating therapies, durvalumab (ImfinziTM) tremelimumab based combinations, and was a key member of the ipilimumab (Yervoy) launch team. Dr. Karasarides holds a Ph.D. in biologybiochemistry and conducted her graduate work on RASPI3K signaling at the Lerner Research Institute, Cleveland Clinical Foundation. During her postdoctoral fellowship at the Institute of Cancer Research, London, UK, she delineated BRAF as a therapeutic target in melanoma.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair:
- William Oh, Mount Sinai
Patient-centric data – Real-World Evidence (RWE) and Real-World Data (RWD) - is becoming instrumental in the drug development process and for health care decisions in general. This data is not only informative for the process from discovery to new indications, clinical trial design, and drug development, it also can be of value to monitor post-marketing drug safety and for decision support in clinical practice. As the data becomes a decision driver, science companies and medical organizations are increasingly focused on leveraging RWD and RWE to not only better understand the patient populations using their drugs and the respective outcomes, but also to accelerate clinical decision support. This session will focus on the various aspects of integrating RWE and RWD to support drug development and clinical decision support.
Sessions:
- PMWC 2024 Award Ceremony
Pioneer Honoree: Atul Butte, UCSF
- Fostering Collaboration: Strategies to Enhance Data Sharing in Medical Research (PANEL)
Chair: Craig Eagle, Guardant Health
- Paul Boutros, UCLA
- Atul Butte, UCSF
- George Sledge, Caris Life Sciences
- Erica Galvez, Manifest MedEx - Regulatory Challenges in Collecting and Using Race and Ethnicity Data in Real-World Evidence
Chair: Susan Winkler, Reagan-Udall Center
- Multi-Modal Datasets & RWE/D: Pioneering Tools for Accelerated Biomedical Research
Chair: TBA
- Data Privacy and Security in RWE/D
Chair: Deven McGraw, Invitae
- Christopher Boone, AbbVie
- Susan Stayn, Stanford
- Alexa Berk King, CVS
- Accelerating Drug Development Approvals Using RWE/D (PANEL)
Chair: Maria Karasarides, BMS
- Leo Russo, Pfizer
- Eric Schadt, Ethos AI
- Ashley Brenton, Optum
